Status:
COMPLETED
A 3D Tablet Sensor Approach to the Measurement of a Lymphedema
Lead Sponsor:
University Hospital, Brest
Conditions:
Lymphedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Up to now, the diagnosis of lymphedema remains hard and delayed. It suffers from many limitations such as lack of coordination and formation of the health-care network. The diversity of used tools is ...
Eligibility Criteria
Inclusion
- \- Unilateral lymphedema
Exclusion
- Minor patient,
- Bilateral lymphedema,
- Trophic disorders: Acute or recent skin infection (\<1 month after the end of antibiotic therapy), unhealed wounds.
- Predictable difficulties in carrying out the measurements due to the patient's physical limitations (maintenance of orthostatic or sitting position \<5 minutes)
- Single or bilateral edema with a different etiology than lymphedema.
Key Trial Info
Start Date :
June 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04821440
Start Date
June 16 2021
End Date
September 23 2021
Last Update
February 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Brest
Brest, France, 29200
2
CH Pont l'Abbé
Pont-l'Abbé, France